Drug Development Groups Life Science 
Digital Health Global
SEPTEMBER 27, 2023
With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation.
Digital Health Global
NOVEMBER 20, 2023
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 29, 2023
With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We
Healthcare IT Today
OCTOBER 6, 2023
The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S., This platform is designed to meet the demands of health systems and life science companies working to solve increasingly global, diverse, and data-intensive healthcare problems.
Digital Health Global
JUNE 20, 2023
Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.
Healthcare IT Today
JANUARY 8, 2024
We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.
Expert insights. Personalized for you.
88 
Let's personalize your content